Bertrand Meresse

Summary

Country: France

Publications

  1. doi request reprint Innate T cell responses in human gut
    Bertrand Meresse
    INSERM U793, Universite Paris Descartes, Medical School, 156 rue de Vaugirard, 75737 Paris Cedex 15, France
    Semin Immunol 21:121-9. 2009
  2. doi request reprint Celiac disease: an immunological jigsaw
    Bertrand Meresse
    INSERM, U989, Universite Paris Descartes, Paris Sorbonne Centre, Institut Imagine, Paris, France
    Immunity 36:907-19. 2012
  3. doi request reprint Large granular lymphocytic leukemia: a treatable form of refractory celiac disease
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Gastroenterology 143:1470-1472.e2. 2012
  4. doi request reprint Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Dig Liver Dis 45:377-84. 2013
  5. pmc IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis
    Georgia Malamut
    INSERM U989, Paris, France
    J Clin Invest 120:2131-43. 2010
  6. ncbi request reprint The cytokine interleukin 21: a new player in coeliac disease?
    Bertrand Meresse
    INSERM U793, Universite Paris Descartes, Faculte de Medecine, 156 rue de Vaugirard, 75730 Paris Cedex 15, France
    Gut 57:879-81. 2008
  7. doi request reprint Refractory celiac disease: from bench to bedside
    Georgia Malamut
    INSERM, U989, Paris, France
    Semin Immunopathol 34:601-13. 2012
  8. doi request reprint Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes
    Julie Schulthess
    INSERM, U989, 75015 Paris, France Université Paris Descartes, Paris Sorbonne Cité, Institut Imagine, France
    Immunity 37:108-21. 2012
  9. doi request reprint Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Gastroenterology 142:726-729.e3; quiz e13-4. 2012
  10. doi request reprint Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Gastroenterology 136:81-90. 2009

Collaborators

Detail Information

Publications11

  1. doi request reprint Innate T cell responses in human gut
    Bertrand Meresse
    INSERM U793, Universite Paris Descartes, Medical School, 156 rue de Vaugirard, 75737 Paris Cedex 15, France
    Semin Immunol 21:121-9. 2009
    ..Herein we discuss how innate-like T cell recognition by unconventional T cell subsets and expression of innate NK receptors might modulate immune T cell responses in the human normal or diseased intestine...
  2. doi request reprint Celiac disease: an immunological jigsaw
    Bertrand Meresse
    INSERM, U989, Universite Paris Descartes, Paris Sorbonne Centre, Institut Imagine, Paris, France
    Immunity 36:907-19. 2012
    ....
  3. doi request reprint Large granular lymphocytic leukemia: a treatable form of refractory celiac disease
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Gastroenterology 143:1470-1472.e2. 2012
    ..Treatment with a combination of cyclosporine and methotrexate restored the patients' sensitivity to gluten-free diets. LGL therefore might be a cause of refractory celiac disease that is sensitive to immunosuppressive therapy...
  4. doi request reprint Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Dig Liver Dis 45:377-84. 2013
    ..How clinical presentation, pathological features and therapies influence outcome was evaluated in 37 thoroughly characterized patients with celiac disease and T-cell lymphoma...
  5. pmc IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis
    Georgia Malamut
    INSERM U989, Paris, France
    J Clin Invest 120:2131-43. 2010
    ..Together, our results delineate the IL-15-driven survival pathway in human IELs and demonstrate that IL-15 and its downstream effectors are meaningful therapeutic targets in RCDII...
  6. ncbi request reprint The cytokine interleukin 21: a new player in coeliac disease?
    Bertrand Meresse
    INSERM U793, Universite Paris Descartes, Faculte de Medecine, 156 rue de Vaugirard, 75730 Paris Cedex 15, France
    Gut 57:879-81. 2008
  7. doi request reprint Refractory celiac disease: from bench to bedside
    Georgia Malamut
    INSERM, U989, Paris, France
    Semin Immunopathol 34:601-13. 2012
    ..Herein, we review the distinctive characteristics of RCD I and RCD II, the mechanisms underlying the onset of resistance to GFD, the risk of developing high grade lymphoma and possible clues to improve their treatment...
  8. doi request reprint Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes
    Julie Schulthess
    INSERM, U989, 75015 Paris, France Université Paris Descartes, Paris Sorbonne Cité, Institut Imagine, France
    Immunity 37:108-21. 2012
    ..Preliminary evidence suggests that this pathway might operate in Crohn's disease...
  9. doi request reprint Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Gastroenterology 142:726-729.e3; quiz e13-4. 2012
    ..Emerging T-cell clones should be monitored in patients with AIE who receive long-term immunosuppressive therapy...
  10. doi request reprint Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II
    Georgia Malamut
    Universite Paris Descartes, Paris, France
    Gastroenterology 136:81-90. 2009
    ..We compared the clinical and biological characteristics of RCD I and RCD II at diagnosis, the risk of developing an overt lymphoma, and the predictive factors of survival...
  11. ncbi request reprint Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease
    Mélika Benahmed
    INSERM U793, Paris, France
    Gastroenterology 132:994-1008. 2007
    ..Our goal has been to investigate why the proinflammatory effects of IL-15 cannot be efficiently controlled by TGF-beta in celiac disease...